Imbalanced serum protein correlations in untreated MS and improvement with IFN-β therapy parallel the extensive dysregulation of mRNA expression in PBMC from untreated MS and the return to near-normal expression with long-term IFN-β therapy [4,47]. The gene discussed is IFNB1; the disease is myeloid sarcoma.